Improved iodine-125 plaque design in the treatment of choroidal malignant melanoma
- PMID: 1739723
- PMCID: PMC504169
- DOI: 10.1136/bjo.76.2.91
Improved iodine-125 plaque design in the treatment of choroidal malignant melanoma
Abstract
The use and development of iodine-125 plaque therapy for choroidal malignant melanoma are described. Since 1975 experience has led to changes in plaque design and insertion techniques. Twenty-one patients were irradiated with local episcleral iodine-125 plaques. Three patients required a second plaque for tumour recurrence. Four eyes were enucleated because of continued tumour growth and a further eye was removed because of glaucoma secondary to radiation retinopathy. Two patients (9.5%) died of metastases. The remaining 19 patients are alive and clinically clear of metastases, with a mean follow up time of 73.1 months (range 43-142 months).
Similar articles
-
Outcomes of choroidal melanomas treated with eye physics: a 20-year review.JAMA Ophthalmol. 2013 Nov;131(11):1435-42. doi: 10.1001/jamaophthalmol.2013.4422. JAMA Ophthalmol. 2013. PMID: 24008431 Clinical Trial.
-
Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study.Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):844-8. doi: 10.1016/j.ijrobp.2009.08.059. Epub 2010 Feb 19. Int J Radiat Oncol Biol Phys. 2010. PMID: 20171804
-
The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma: IV. Local Treatment Failure and Enucleation in the First 5 Years after Brachytherapy. COMS Report No. 19.Ophthalmology. 2020 Apr;127(4S):S148-S157. doi: 10.1016/j.ophtha.2020.01.032. Ophthalmology. 2020. PMID: 32200815 Clinical Trial.
-
Episcleral plaque radiotherapy for uveal melanoma.Aust N Z J Ophthalmol. 1989 May;17(2):153-6. doi: 10.1111/j.1442-9071.1989.tb00505.x. Aust N Z J Ophthalmol. 1989. PMID: 2667581 Review.
-
Ocular complications following I-125 brachytherapy for choroidal melanoma.Eye (Lond). 2009 Jun;23(6):1254-68. doi: 10.1038/eye.2009.43. Epub 2009 Mar 6. Eye (Lond). 2009. PMID: 19265865 Review.
Cited by
-
Investigation of gold nanoparticle effects in brachytherapy by an electron emitter ophthalmic plaque.Int J Nanomedicine. 2019 Jun 6;14:4157-4165. doi: 10.2147/IJN.S205814. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31239674 Free PMC article.
-
Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.Trans Am Ophthalmol Soc. 2002;100:43-8; discussion 48-9. Trans Am Ophthalmol Soc. 2002. PMID: 12545676 Free PMC article.
-
Internal resection of posterior uveal melanomas.Br J Ophthalmol. 1998 Oct;82(10):1147-53. doi: 10.1136/bjo.82.10.1147. Br J Ophthalmol. 1998. PMID: 9924302 Free PMC article.
-
A randomized, controlled trial of varying radiation doses in the treatment of choroidal melanoma.Trans Am Ophthalmol Soc. 1998;96:691-720. Trans Am Ophthalmol Soc. 1998. PMID: 10360306 Free PMC article. Clinical Trial. No abstract available.
-
I-125 brachytherapy for choroidal melanoma photographic and angiographic abnormalities: the Collaborative Ocular Melanoma Study: COMS Report No. 30.Ophthalmology. 2009 Jan;116(1):106-115.e1. doi: 10.1016/j.ophtha.2008.10.013. Ophthalmology. 2009. PMID: 19118701 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical